How well do health systems monitor HIV-associated comorbidities? HIV Outcomes at HIV Drug Therapy Glasgow 2018
News
25 October 2018

How well do health systems monitor HIV-associated comorbidities? HIV Outcomes at HIV Drug Therapy Glasgow 2018

Steering group co-chair Professor Jane Anderson (Consultant Physician, Homerton University Hospital, London) will present findings from HIV Outcomes' assessment of how effectively health systems are monitoring HIV-associated comorbidities at this year's HIV Drug Therapy conference in Glasgow on 28-31 October 2018.

While HIV has become a chronic condition, evidence suggests that there are a growing number of people living with HIV suffering from non-AIDS-defining comorbidities. Using current global and European frameworks, the HIV Outcomes abstract assesses whether existing monitoring frameworks sufficiently enable European countries to observe and understand the comorbidities that impact on the health and well-being of people living with HIV.

The abstract is taken from research work being undertaken by the HIV Outcomes study group.

More updates All

Report
14 February 2020
With the aim of focusing European thought-leadership on delivering the greatest potential impact at national level, the HIV Outcomes Steering Group ‘road-tested’ the HIV Outcomes recommendations in Germany and Romania ...
More
News
18 December 2019
HIV has fallen off the EU’s political agenda but MEPs, patients, clinicians and academics put the spotlight on long-term health and well-being of people living with HIV at a ...
More
Press Releases
26 November 2019
Strasbourg, 26 November 2019: HIV Outcomes will today launch a Call to Action urging European policymakers to ensure that long-term health outcomes and the quality of life of people with HIV are high on the political agenda. At a roundtable event in ...
More
Filters
Initiative Partners
  • Aids Action Europe
  • AFEW International
  • East Europe and Central Asia Union of PLWH
  • European AIDS Treatment Group
  • Gilead
  • ViiV Healthcare
This initiative is enabled by sponsorship provided by Gilead Sciences and ViiV Healthcare.